Saturday 7 November 2026 Export ZVRA’s income statement to Excel — free account

Zevra Therapeutics, Inc.

Zevra Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $106.5 million, up 350.9% from fiscal 2024.

Revenue: +44.9%
EPS: +3,333.0%
Free cash flow: +106.8%
Total debt: +4.07%

Quarter to September 2026, against a year earlier

11.55 1.02 +9.69%

Follow ZVRA

Alert me

Market cap: $626.6M
P/E: 9.0×
Fwd P/E: 9.2×
Dividend yield: —
F-score: 6/9
Altman Z: 0.63
Beneish M: 1.46
Dividend safety: n/a

Overview

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
Piotroski F-Score Full definition →	6	6	7	6	+8 more TTM periods Free account
ROE Full definition →	40.29%	33.44%	93.60%	78.32%
ROA Full definition →	25.69%	20.03%	51.19%	32.88%
ROIC Full definition →	129.48%	0.00%	(65.48%)	(153.83%)
Return on Tangible Assets Full definition →	40.46%	27.54%	62.99%	41.31%
Average Days of Receivables Full definition →	49.26	60.33	65.96	79.73
Free Cash Flow per Share Full definition →	1.47	1.39	0.21	(0.04)
Free Cash Flow Full definition →	87.07	82.01	12.49	(1.98)
Capital Expenditures Full definition →	48.34	48.61	(0.28)	(0.39)
Other line items
Cash ROIC Full definition →	20.04%	18.67%	3.07%	(0.49%)
Accounts Receivable Turnover Full definition →	8.03	6.68	7.05	6.31
Accounts Payable Turnover Full definition →	0.54	0.41	1.15	0.89
Inventory Turnover Full definition →	3.04	3.47	7.00	8.89
Average Days of Payables Full definition →	740.84	824.62	250.45	256.84
Days of Inventory on Hand Full definition →	166.35	144.64	49.50	38.53
Tax Rate Full definition →	(0.13)	(0.16)	(0.07)	(0.04)
Research and Development Expense of Revenue Full definition →	11.12%	10.97%	11.35%	11.97%
Selling, General and Administrative Expense of Revenue Full definition →	51.99%	54.85%	64.48%	72.90%
Share Based Compensation of Revenue Full definition →	8.82%	9.65%	10.32%	11.94%
Interest Coverage Full definition →	24.55	14.43	(0.70)	(7.89)
Operating CF/Net income Full definition →	0.52	0.60	0.11	(0.02)
Depreciation/Fixed assets Full definition →	(0.72)	(2.81)	134.97	121.96
Capex/Depreciation Full definition →	(82.34)	(26.99)	0.00	(0.01)
Revenue per Share Full definition →	2.49	2.30	2.09	1.92
Operating CF per Share Full definition →	0.65	0.56	0.22	(0.03)
Capex per Share Full definition →	0.81	0.82	0.00	(0.01)
Capex to Sales Full definition →	(0.33)	(0.36)	0.00	0.00

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly